首页> 外文期刊>BMC Medical Informatics and Decision Making >ApreciseKUre: an approach of Precision Medicine in a Rare Disease
【24h】

ApreciseKUre: an approach of Precision Medicine in a Rare Disease

机译:ApreciseKUre:一种罕见疾病中的精准医学方法

获取原文
           

摘要

Background Alkaptonuria (AKU; OMIM:203500) is a classic Mendelian genetic disorder described by Garrod already in 1902. It causes urine to turn black upon exposure to air and also leads to ochronosis as well as early osteoarthritis. Main body of the Our objective is the implementation of a Precision Medicine (PM) approach to AKU. We present here a novel ApreciseKUre database facilitating the collection, integration and analysis of patient data in order to create an AKU-dedicated “PM Ecosystem” in which genetic, biochemical and clinical resources can be shared among registered researchers. In order to exploit the ApreciseKUre database, we developed an analytic method based on Pearson’s correlation coefficient and P value that generates as refreshable correlation matrix. A complete statistical analysis is obtained by associating every pair of parameters to examine the dependence between multiple variables at the same time. Short conclusions Employing this analytic approach, we showed that some clinically used biomarkers are not suitable as prognostic biomarkers in AKU for a more reliable patients’ clinical monitoring. We believe this database could be a good starting point for the creation of a new clinical management tool in AKU, which will lead to the development of a deeper knowledge network on the disease and will advance its treatment. Moreover, our approach can serve as a personalization model paradigm for other inborn errors of metabolism or rare diseases in general.
机译:背景碱性磷酸酶尿症(AKU; OMIM:203500)是Garrod于1902年描述的一种典型的孟德尔遗传病。暴露于空气中后,尿液会变黑,并导致经时变性以及早期骨关节炎。我们目标的主体是对AKU实施精确医学(PM)方法。我们在这里介绍一个新颖的ApreciseKUre数据库,该数据库有助于收集,整合和分析患者数据,以创建一个AKU专用的“ PM生态系统”,在该系统中可以在注册研究人员之间共享遗传,生化和临床资源。为了利用ApreciseKUre数据库,我们开发了一种基于Pearson相关系数和P值的分析方法,该方法生成为可刷新的相关矩阵。通过关联每对参数以同时检查多个变量之间的依赖性,可以获得完整的统计分析。简短的结论利用这种分析方法,我们发现某些临床使用的生物标志物不适合作为AKU中的预后生物标志物,以进行更可靠的患者临床监测。我们认为,该数据库可能是在AKU中创建新的临床管理工具的良好起点,这将导致开发有关该疾病的更深入的知识网络并促进其治疗。而且,我们的方法可以用作其他先天性代谢错误或一般罕见病的个性化模型范式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号